Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd. is a renowned pharmaceutical company based in Japan, primarily engaged in the creation and distribution of medicinal products. The company's core mission is to develop innovative treatments that improve patients' quality of life through cutting-edge pharmaceutical research and development. Ono Pharmaceutical plays a significant role in the healthcare sector by focusing on therapeutic areas such as oncology, immunology, cardiovascular diseases, and neuroscience. Among its significant contributions, the company is known for co-developing the immuno-oncology drug Opdivo, a monoclonal antibody used in cancer treatment. Headquartered in Osaka, Ono Pharmaceutical serves a global market, continually seeking breakthroughs in medicine through collaboration with other leading pharmaceutical entities. Its dedication to R&D and contribution to modern healthcare solidifies its importance in advancing medical therapies and addressing critical global health challenges.

CEO

Mr. Gyo Sagara

Employees

4,287

Website

ono-pharma.com